Trials / Completed
CompletedNCT00330486
Open Label Trial of Acamprosate in Bipolar Alcoholics
The Use of Acamprosate in Alcohol-Dependent Individuals With Bipolar Disorder
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether acamprosate (Campral) is safe and effective in treating alcohol dependence in individuals with bipolar disorder. All subjects in the study must be currently stabilized on mood-stabilizing medication. Half of the subjects will receive acamprosate in addition to their mood-stabilizing medication; control subjects will be maintained on their mood-stabilizing medication alone. Measures of alcohol use as well as mood stability will be obtained weekly throughout the active phase of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acamprosate |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2006-05-26
- Last updated
- 2008-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00330486. Inclusion in this directory is not an endorsement.